LOGWX | Developing Growth Fund Class F3 | Lord Abbett
Image alt tag

Error!

There was a problem contacting the server. Please try after sometime.

Sorry, we are unable to process your request.

Error!

We're sorry, but the Insights and Intelligence Tool is temporarily unavailable

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Error!

We're sorry, but the Literature Center checkout function is temporarily unavailable.

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

Reset Your Password

Financial Professionals*

Your password must be a minimum of characters.

Confirmation Message

Your LordAbbett.com password was successully updated. This page will be refreshed after 3 seconds.

OK

 

Developing Growth Fund

Summary

Summary

What is the Developing Growth Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.

 

Fund Basicsas of 09/30/2021

Total Net Assets
$4.82 B
Inception Date
04/05/2017
Dividend Frequency
Annually
Fund Expense Ratio
0.60%
Number of Holdings
101

Fund Expense Ratio :

0.60%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 0.99% 28.77% 20.76% 24.97% 19.10% -
Lipper Category Avg. Small-Cap Growth Funds 9.07% 37.87% 15.14% 17.85% 16.15% -
Russell 2000® Growth Index 2.82% 33.27% 11.70% 15.34% 15.74% -

Fund Expense Ratio :

0.60%

Fund Expense Ratio :

0.60%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 0.99% 28.77% 20.76% 24.97% 19.10% -
Lipper Category Avg. Small-Cap Growth Funds 9.07% 37.87% 15.14% 17.85% 16.15% -
Russell 2000® Growth Index 2.82% 33.27% 11.70% 15.34% 15.74% -

Fund Expense Ratio :

0.60%

TEN LARGEST HOLDINGS as of 09/30/2021View Portfolio

Holding Assets
Crocs Inc 2.5%
Chart Industries Inc 2.2%
Axon Enterprise, Inc. 2.1%
Inmode Ltd 2.0%
Shockwave Medical Inc 1.9%
Calix Inc 1.8%
Diodes Inc 1.8%
Endava PLC 1.8%
Semtech Corp 1.8%
Tempur Sealy International Inc 1.8%

INVESTMENT TEAM

F. Thomas O'Halloran
F. Thomas O'Halloran, CFA, J.D.

Partner & Portfolio Manager

33 Years of Industry Experience

Matthew R. DeCicco
Matthew R. DeCicco, CFA

Partner & Director of Equities

21 Years of Industry Experience

Vernon Bice
Vernon Bice, CMT

Portfolio Manager

19 Years of Industry Experience

Ben Ebel
Ben Ebel

Portfolio Manager

28 Years of Industry Experience

Supported By 6 Investment Professionals with 18 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

0.60%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 0.99% 28.77% 20.76% 24.97% 19.10% -
Lipper Category Avg. Small-Cap Growth Funds 9.07% 37.87% 15.14% 17.85% 16.15% -
Russell 2000® Growth Index 2.82% 33.27% 11.70% 15.34% 15.74% -

Fund Expense Ratio :

0.60%

Fund Expense Ratio :

0.60%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 0.99% 28.77% 20.76% 24.97% 19.10% -
Lipper Category Avg. Small-Cap Growth Funds 9.07% 37.87% 15.14% 17.85% 16.15% -
Russell 2000® Growth Index 2.82% 33.27% 11.70% 15.34% 15.74% -

Fund Expense Ratio :

0.60%

Year Fund Returns Russell 2000® Growth Index
2020 73.04% 34.63%
2019 32.39% 28.48%
2018 5.46% -9.31%
2017 30.39% 22.17%
2016 -2.33% 11.32%
2015 -8.49% -1.38%
2014 3.70% 5.60%
2013 57.99% 43.30%
2012 10.88% 14.59%
2011 -1.16% -2.91%
2010 37.21% -
2009 47.74% -
2008 -47.24% -
2007 36.48% -
2006 - -
Year Q1 Q2 Q3 Q4 Yearly Returns
2021 1.73% 2.98% -3.59% - 3.79%
2020 -16.88% 40.72% 16.03% 27.50% 73.04%
2019 27.08% 9.20% -11.28% 7.54% 32.39%
2018 7.25% 15.08% 12.26% -23.88% 5.46%
2017 8.48% 4.13% 7.16% 7.73% 30.39%
2016 -10.23% 2.33% 10.98% -4.20% -2.33%
2015 7.22% 2.73% -15.60% -1.57% -8.49%
2014 1.80% 0.28% -5.68% 7.70% 3.70%
2013 13.64% 10.16% 18.92% 6.12% 57.99%
2012 12.28% -2.56% 5.70% -4.12% 10.88%
2011 10.36% 1.64% -20.75% 11.20% -1.16%
2010 8.29% -7.81% 16.65% 17.83% 37.21%
2009 -2.02% 24.54% 14.28% 5.95% 47.74%
2008 -21.72% 6.73% -11.66% -28.51% -47.24%
2007 4.79% 13.71% 10.00% 4.13% 36.48%
2006 - - - 11.12% -

NAV Historical Prices

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioning as of 6/30/2021

  • The U.S. equity market continues to be healthy, trading at or near all-time highs with solid breadth. Earlier in the month of June, the U.S. Federal Reserve (Fed) signaled it would taper sooner and the market sold off modestly. The reaction to the Fed meeting was orderly – the U.S. 10-year Treasury did not move much, and although volatility rose sharply, the VIX remained at a reasonable level (neither too complacent nor too worried).
  • In addition, Innovation Growth stocks traded well following the Fed meeting indicating an ongoing healthy rotation. Our other key technical indicators continue to be positive. Over the last month, the portfolio has tilted slightly back to secular growth given the expectation of lower bond yields in the near term, combined with continued strong fundamentals within the information technology, consumer, and communication services sectors heading into the Q2 earnings season.
  • Our active approach continues to focus on identifying high innovation companies with both operating momentum and price momentum, and it is through this lens that we continuously assess our portfolio and developments in the broader economy.

Portfolio Details as of 09/30/2021

Total Net Assets
$4.82 B
Number of Holdings
101
Weighted Average Market Cap.
6.1 B
P/B Ratio
6.7x
P/E Ratio
28.5x

Contributors & Detractors as of  09/30/2021

Contributors

Holding Contribution
Inmode Ltd 0.8%
Crocs Inc 0.5%
Chart Industries, Inc. 0.5%
Globant SA 0.5%
Sprout Social Inc 0.5%

Detractors

Holding Contribution
Protagonist Therapeutic -0.5%
Caredx Inc -0.5%
Digital Turbine Inc -0.4%
Shift4 Pmts Inc -0.3%
Editas Medicine Inc -0.3%

Attribution Analysis 

Developing Growth Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Dividends & Cap Gains

Dividends & Cap Gains

Upcoming Dividend Payment Dates

This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
11/22/2021 11/23/2021 11/23/2021

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
11/23/2020 11/24/2020 $2.1959 $0.7588 $2.9547 $35.02

Upcoming Capital Gain Distribution

This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date
11/22/2021 11/23/2021

Fees & Expenses

Fees & Expenses

Expense Ratioas of 09/30/2021

0.60%

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
n/a
Portfolio Holdings 1Q
Publish Date:11/03/2015
n/a
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
n/a
Prospectus (XBRL)
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015
Fund Story
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

The Russell 2000® Growth Index measures the performance of those Russell 2000 companies with higher price-to-book ratios and higher forecasted growth values.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field